All news

BlackRock trims ChemoMetec share voting rights below 15%

Alpha Vantage · Yahoo Finance UK · · AI-summarised by FinFlash

BlackRock cut its voting rights attached to ChemoMetec A/S shares to 14.97% on October 15, 2026, dropping below the 15% threshold. Its voting rights held through financial instruments rose to 0.11%, leaving the combined position at 15.08%. The shift is a technical reclassification rather than an exit, so the aggregate stake is essentially unchanged for investors tracking ownership.

Read original source

BLK company analysis

Understand the context

Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.